BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22032899)

  • 1. Vesicular stomatitis virus matrix protein (VSVMP) inhibits the cell growth and tumor angiogenesis in oral squamous cell carcinoma.
    Zhou Y; Zhu X; Lu R; Dan H; Wang F; Wang J; Li J; Feng X; Wang H; Ji N; Zhou M; Zeng X; Jiang L; Chen Q
    Oral Oncol; 2012 Feb; 48(2):110-6. PubMed ID: 22032899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient inhibition of intraperitoneal human ovarian cancer growth and prolonged survival by gene transfer of vesicular stomatitis virus matrix protein in nude mice.
    Lin X; Chen X; Wei Y; Zhao J; Fan L; Wen Y; Wu H; Zhao X
    Gynecol Oncol; 2007 Mar; 104(3):540-6. PubMed ID: 17112567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix protein of vesicular stomatitis virus: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation.
    Zhou Y; Wen F; Zhang P; Tang R; Li Q
    Cancer Gene Ther; 2013 Mar; 20(3):178-85. PubMed ID: 23449478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference-mediated downregulation of hypoxia-inducible factor-1α inhibits angiogenesis and survival of oral squamous cell carcinoma in vitro and in vivo.
    Zhou H; Fei W; Bai Y; Zhu S; Luo E; Chen K; Hu J
    Eur J Cancer Prev; 2012 May; 21(3):289-99. PubMed ID: 22113109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
    Harada K; Supriatno ; Yoshida H; Sato M
    Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Squamous Cell Carcinoma-derived Sonic Hedgehog Promotes Angiogenesis.
    Kuroda H; Kurio N; Shimo T; Matsumoto K; Masui M; Takabatake K; Okui T; Ibaragi S; Kunisada Y; Obata K; Yoshioka N; Kishimoto K; Nagatsuka H; Sasaki A
    Anticancer Res; 2017 Dec; 37(12):6731-6737. PubMed ID: 29187450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinoma.
    Myoung H; Hong SD; Kim YY; Hong SP; Kim MJ
    Cancer Lett; 2001 Feb; 163(2):191-200. PubMed ID: 11165754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient inhibition of cisplatin-resistant human ovarian cancer growth and prolonged survival by gene transferred vesicular stomatitis virus matrix protein in nude mice.
    Zhong Q; Wen YJ; Yang HS; Luo H; Fu AF; Yang F; Chen LJ; Chen X; Qi XR; Lin HG; Wan Y; Chen XC; Wei YQ; Zhao X
    Ann Oncol; 2008 Sep; 19(9):1584-91. PubMed ID: 18436522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation.
    Sappayatosok K; Maneerat Y; Swasdison S; Viriyavejakul P; Dhanuthai K; Zwang J; Chaisri U
    Med Oral Patol Oral Cir Bucal; 2009 Jul; 14(7):E319-24. PubMed ID: 19300368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
    Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
    Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor effect of a novel FAK inhibitor TAE226 against human oral squamous cell carcinoma.
    Kurio N; Shimo T; Fukazawa T; Okui T; Hassan NM; Honami T; Horikiri Y; Hatakeyama S; Takaoka M; Naomoto Y; Sasaki A
    Oral Oncol; 2012 Nov; 48(11):1159-70. PubMed ID: 22766511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
    Shang ZJ; Li JR
    J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral cancer overexpressed 1 (ORAOV1): a regulator for the cell growth and tumor angiogenesis in oral squamous cell carcinoma.
    Jiang L; Zeng X; Yang H; Wang Z; Shen J; Bai J; Zhang Y; Gao F; Zhou M; Chen Q
    Int J Cancer; 2008 Oct; 123(8):1779-86. PubMed ID: 18688849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of novel HSP90 inhibitor NVP-AUY922 against oral squamous cell carcinoma.
    Okui T; Shimo T; Hassan NM; Fukazawa T; Kurio N; Takaoka M; Naomoto Y; Sasaki A
    Anticancer Res; 2011 Apr; 31(4):1197-204. PubMed ID: 21508365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WISP-1 a novel angiogenic regulator of the CCN family promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression.
    Chuang JY; Chen PC; Tsao CW; Chang AC; Lein MY; Lin CC; Wang SW; Lin CW; Tang CH
    Oncotarget; 2015 Feb; 6(6):4239-52. PubMed ID: 25738362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
    Tamatani T; Azuma M; Motegi K; Takamaru N; Kawashima Y; Bando T
    Int J Oncol; 2007 Oct; 31(4):761-8. PubMed ID: 17786306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of transcription factor Sp1 in the 4-O-methylhonokiol-mediated apoptotic effect on oral squamous cancer cells and xenograft.
    Cho JH; Lee RH; Jeon YJ; Shin JC; Park SM; Choi NJ; Seo KS; Yoon G; Cho SS; Kim KH; Cho JJ; Cho YS; Kim DH; Hong JT; Lee TH; Park HJ; Jung S; Seo JM; Chen H; Dong Z; Chae JI; Shim JH
    Int J Biochem Cell Biol; 2015 Jul; 64():287-97. PubMed ID: 25982202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
    Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
    Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Toll-like receptor 3 induces apoptosis of oral squamous carcinoma cells in vitro and in vivo.
    Luo Q; Hu S; Yan M; Sun Z; Chen W; Chen F
    Int J Biochem Cell Biol; 2012 Aug; 44(8):1266-75. PubMed ID: 22568929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.